Pharmacokinetics and pharmacodynamics of Dabigatran Etexilate and Rivaroxaban in patients requiring PArenteral Nutrition
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Catheter thrombosis; Short bowel syndrome
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms PDER-PAN
- 01 Dec 2017 Status changed from recruiting to completed, as per the results published in the Thrombosis Research
- 18 Oct 2013 New trial record